BioLineRx to Report Second Quarter 2026 Results on August 31, 2026
PR Newswire•25/08/2026•07:00 ET
0
Whiz Insights
BioLineRx to Report Second Quarter 2026 Results on August 31, 2026
TEL AVIV, Israel, Aug. 25, 2026 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2026 on Monday, August 31, 2026, before the U.S. markets open.
Get started
Create a free account to read the full story.